GVS logo

GVS S.p.A. Stock Price

BIT:GVS Community·€779.4m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

GVS Share Price Performance

€4.16
-0.58 (-12.14%)
€5.98
Fair Value
€4.16
-0.58 (-12.14%)
30.4% undervalued intrinsic discount
€5.98
Fair Value
Price €4.16
AnalystConsensusTarget €5.98
AnalystLowTarget €5.30
AnalystHighTarget €7.50

GVS Community Narratives

AnalystConsensusTarget·
Fair Value €5.98 30.4% undervalued intrinsic discount

Transfusion Medicine And Clean Energy Applications Will Drive Stronger Long Term Prospects

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AnalystLowTarget·
Fair Value €5.3 21.5% undervalued intrinsic discount

Hydrogen Membranes And Life Sciences May Outweigh Mobility Weakness Over Time

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystHighTarget·
Fair Value €7.5 44.5% undervalued intrinsic discount

Plant Transfers And Hydrogen Membranes Will Transform Profitability Over The Next Decade

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
€7.5
44.5% undervalued intrinsic discount
Revenue
8.41% p.a.
Profit Margin
15.75%
Future PE
22.48x
Price in 2029
€10.42
€5.98
30.4% undervalued intrinsic discount
Revenue
6.23% p.a.
Profit Margin
14.9%
Future PE
20.17x
Price in 2028
€8.33
€5.3
21.5% undervalued intrinsic discount
Revenue
4.54% p.a.
Profit Margin
14.75%
Future PE
18.97x
Price in 2028
€7.38

Trending Discussion

Updated Narratives

GVS logo

Plant Transfers And Hydrogen Membranes Will Transform Profitability Over The Next Decade

Fair Value: €7.5 44.5% undervalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
GVS logo

Transfusion Medicine And Clean Energy Applications Will Drive Stronger Long Term Prospects

Fair Value: €5.98 30.4% undervalued intrinsic discount
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
GVS logo

Hydrogen Membranes And Life Sciences May Outweigh Mobility Weakness Over Time

Fair Value: €5.3 21.5% undervalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Reasonable growth potential with acceptable track record.

2 Risks
3 Rewards

GVS S.p.A. Key Details

€422.4m

Revenue

€187.7m

Cost of Revenue

€234.7m

Gross Profit

€211.9m

Other Expenses

€22.9m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
0.12
55.57%
5.41%
68.9%
View Full Analysis

About GVS

Founded
1979
Employees
4234
CEO
Massimo Scagliarini
WebsiteView website
www.gvs.com

GVS S.p.A., together with its subsidiaries, produces and sells filter solutions for applications in the healthcare and life sciences, energy and mobility, and health and safety sectors in Italy and internationally. The company offers health and safety products, such as hand dryer and vacuum cleaner filters; nailstation COSMO products; fume extraction and HVAC building products; and disposable masks, half masks, integra masks, powered air purifying respirators, face fit testing, replacement filters, supplied air respirators, spare parts, and accessories. It also provides autoclave filters, insufflation and ventilation filters and kits, machine filters, respiratory and anesthesia filters, smoke evacuation filters and kits, spirometry filters and accessories, suction filters, and tracheal humidifier filters; healthcare liquid products, such as bacterial air vents, blood tubular filters, infusion disc filters, IV and liquid filters, IV flow regulators, medical bags and components, sterile infusion sets and accessories, stopcock and manifold products, and transducer protectors; and capsule and cartridge filters, disc and sheet membranes, mini roll membranes, DNA/RNA test kits, filter papers, microbiology products, microfiltration devices, microporous and track etched roll membranes, protein microarrays, and environmental monitoring products, as well as western blotting membranes and reagents. In addition, the company offers energy and mobility products, such as fuel tanks and pumps, metal components, reservoirs, and SCR urea systems; ABS, ESP, and brake systems; EV applications and batteries; injection, tank vapour ventilation, and transmission products; ventilation systems; and cabin air and HVAC systems, and engine air intake ventilation filters. The company was formerly known as GVS S.r.l. and changed its name to GVS S.p.A. in 2001. GVS S.p.A. was founded in 1979 and is headquartered in Zola Predosa, Italy. GVS S.p.A. is a subsidiary of GVS Group S.r.l.

Recent GVS News & Updates

Recent updates

No updates